Canaccord Genuity Starts Aegerion Pharmaceuticals (AEGR) at Buy
Tweet Send to a FriendGet Alerts AEGR Hot Sheet
Price: $60.02 -0.15%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade AEGR Now!
Canaccord Genuity initiates coverage on Aegerion Pharmaceuticals (NASDAQ: AEGR) with a Buy. PT $27.00.
For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.
Shares of Aegerion Pharmaceuticals closed at $14.00 yesterday, with a 52 week range of $11.80-$25.92.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.
Shares of Aegerion Pharmaceuticals closed at $14.00 yesterday, with a 52 week range of $11.80-$25.92.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
- Aegerion (AEGR) Pops on Juxtapid Price Increase; Leerink Boosts PT to $65
- Deutsche Bank Takes Aegerion (AEGR) Price Target from $52 to $85
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
